EUVIMEDEUVIMED entdecken
Crossref

HERBAL ANTI-INFLAMMATORY AGENTS: MOLECULAR MECHANISMS, PHARMACOLOGICAL EVIDENCE, AND CLINICAL PROSPECTS

PATTHE V. K., CHARHATE K. B., GHUBE D. D., TATHE P R

International Journal of Drug Delivery Technology · 18.05.2026 · 16 (28s)

DOI: 10.25258/ijddt.16.28s.92 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 18.05.2026. Verfasst von PATTHE V. K. und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammation represents a highly coordinated biological defense mechanism essential for maintaining physiological equilibrium; however, its persistent activation is a critical contributor to the development of chronic pathological conditions, including autoimmune disorders, neurodegenerative diseases, metabolic syndromes, and malignancies. Although conventional pharmacological interventions such as nonsteroidal anti-inflammatory drugs (NSAIDs) and corticosteroids remain the cornerstone of therapy, their prolonged use is frequently limited by significant adverse effects. This has prompted growing interest in plant-based therapeutics as safer and multi-target alternatives. Medicinal plants are abundant in structurally diverse bioactive compounds—including flavonoids, polyphenols, alkaloids, and terpenoids—that exert anti-inflammatory effects through interconnected molecular pathways. These compounds modulate inflammatory processes by inhibiting cyclooxygenase and lipoxygenase enzymes, suppressing nuclear factorkappa B (NF-κB) signaling, regulating cytokine production, and mitigating oxidative stress. The present review critically synthesizes current knowledge on the pharmacological mechanisms, therapeutic relevance, clinical evidence, and emerging formulation strategies of herbal anti-inflammatory agents. Furthermore, it addresses existing challenges such as bioavailability limitations, lack of standardization, and regulatory barriers, while outlining future research directions for their integration into evidence-based medicine.

Zitieren

APA

K., P. V., B., C. K., D., G. D., & R, T. P. (2026). HERBAL ANTI-INFLAMMATORY AGENTS: MOLECULAR MECHANISMS, PHARMACOLOGICAL EVIDENCE, AND CLINICAL PROSPECTS. International Journal of Drug Delivery Technology, 16(28s). https://doi.org/10.25258/ijddt.16.28s.92

Vancouver

K. PV, B. CK, D. GD, R TP. HERBAL ANTI-INFLAMMATORY AGENTS: MOLECULAR MECHANISMS, PHARMACOLOGICAL EVIDENCE, AND CLINICAL PROSPECTS. International Journal of Drug Delivery Technology. 2026;16(28s). doi:10.25258/ijddt.16.28s.92

BibTeX
@article{K2026,
  author = {K., PATTHE V. and B., CHARHATE K. and D., GHUBE D. and R, TATHE P},
  title = {HERBAL ANTI-INFLAMMATORY AGENTS: MOLECULAR MECHANISMS, PHARMACOLOGICAL EVIDENCE, AND CLINICAL PROSPECTS},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {28s},
  doi = {10.25258/ijddt.16.28s.92}
}
Kostenlos starten →